Share:

On Thursday 2 April, the European Commission published its much anticipated Evaluation Report (ER) on the legislative framework for tobacco control (TPD).  

Not an evaluation. The report notes the small decline in smoking between 2012 and 2023 from 28% to 24% and attributes this decline, without evidence, to the EU tobacco control framework. There is nothing in the ER that shows that any of the policies in the TPD or TAD had any effect, or that some policies worked while others did not, and no comparisons are made with declines in other countries or globally. The Evaluation Report is a bureaucrats’ evaluation, focussed on rule-making activity, implementation, and compliance: it does not address whether the tobacco control framework is an effective public health or consumer protection regime.

Obvious insights from within the EU were ignored. No attempt is made in the evaluation to explain the pronounced differences in smoking prevalence in the Member States [Smoking prevalence in Sweden = 8% Greece = 36% in 2023], especially as they are all operating within the same framework, with the exception of Sweden’s exemption from the snus ban. The most overt outliers are the Nordics (Sweden, Norway, Iceland and Finland) and the obvious conclusion - that snus has substantially displaced smoking - has been conspicuously avoided. The report claims the framework has enabled “the smooth functioning of the internal market, while ensuring a high level of human health protection”, but without explaining how banning one of the safest nicotine products, snus, is consistent with pro-health competition.  

No understanding of the migration of nicotine use to lower risk products, especially in young people. The report emphasises the steeper decline in smoking among young people (15-24) from 29% to 22%, but ignores the likely cause: the greater uptake of vaping in young people displacing smoking and diverting from smoking initiation. It’s hard to find a credible analysis of youth vaping that does not show significant beneficial substitution. 

Most of the Evaluation Report is preparing the ground for new prohibitionist measures. The ER is relentlessly negative about the emergence of much safer products than cigarettes, following well trodden narratives developed by academics, activists, foundations and other motivated interest groups: For example:

  • It appears complacent about the 94 million EU citizens who still smoke and focuses on hostile analysis of safer alternatives to smoking, denying the opportunity of tobacco harm reduction and repeating the errors that led to the snus ban.
  • It goes far beyond the science in attributing high risks to non-combustible nicotine products while ignoring the strong scientific base showing pronounced difference in risks. It consistently conflates “tobacco” and “smoking”, even though heated and oral tobacco products are far less risky than combustible tobacco. 
  • Shows no grasp of the motivation of consumers or why flavours are an important aspect of product appeal as an alternative to smoking. Bans or other measures that degrade the appeal of safer products will expand the market for more dangerous products.
  • It rehearses debunked arguments about gateway effects and misrepresents the role of smoke-free alternatives in smoking cessation (vapes are both popular and effective).
  • It fails to evaluate harmful unintended consequences arising from current or potential future EU policies. For example, did the 2ml tank size limit increase waste created by disposable vapes? Did the ban on advertising vapes protect the incumbent cigarette trade? Does the cap on nicotine strength make vapes ineffective for more dependent smokers? It shows no interest in these questions and many more like them.

It fails to evaluate illicit trade, yet the recent Fraunhofer Institute Report (March 2026) estimated 48% of vape sales in Europe are “irregular”.  The Commission presents no useful data on illicit trade, yet the risk of creating a giant criminal market should constrain policymakers concerned about both well functioning markets and organised crime.

The Commission seems to neither understand nor want to understand why consumers switch from cigarettes to safer nicotine products, even though 89% of respondents from Open Public consultation were from citizens and 72% of those were consumers of safer nicotine products presenting insights and lived experience that find no expression in the Evaluation Report.

For the internal market to function correctly and to work for health, the Commission must base its policies on fundamental principles of proportionality and non-discrimination. Treating all nicotine products as if they pose equal harm violates these principles does not protect public health. It will protect the cigarette trade, harm EU citizens, and nurture organised crime.

If the European Union is serious about reducing smoking rates, cancer and cardiovascular disease, it must move beyond rigid frameworks and ideological resistance. It must listen to consumers, engage honestly with the evidence, and embrace harm reduction as a legitimate and necessary strategy. Anything less will entrench the problem the TPD was meant to solve.

Further information

The negative opinion of the EU Regulatory Scrutiny Board SEC(2026)111.